...
首页> 外文期刊>European review for medical and pharmacological sciences. >Omega-3 polyunsaturated fatty acids alleviate adenine-induced chronic renal failure via regulating ROS production and TGF-β/SMAD pathway
【24h】

Omega-3 polyunsaturated fatty acids alleviate adenine-induced chronic renal failure via regulating ROS production and TGF-β/SMAD pathway

机译:Omega-3多不饱和脂肪酸通过调节ROS的产生和TGF-β/ SMAD途径缓解腺嘌呤诱发的慢性肾功能衰竭

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To explore the role of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in adenine-induced rat chronic renal failure and its underlying mechanism. MATERIALS AND METHODS: 30 Sprague Dawley (SD) rats were randomly assigned into three groups, namely sham group, adenine induction group (adenine group) and adenine induction + ω-3 PUFAs treatment group (ω-3 PUFAs group), with 10 rats in each group. Serum and kidney samples were collected after rats were sacrificed. Serum levels of Cr (creatinine) and BUN (urea nitrogen) were detected using commercial kits. HE (hematoxylin and eosin) staining was performed to evaluate the pathological changes of kidneys. Levels of oxidative stress indicators in rat kidney homogenate were detected by relative commercial kits, including SOD (superoxide dismutase), GSH (reduced glutathione), CAT (catalase), and T-AOC (total antioxidant capacity). Reactive oxygen species (ROS) production was also detected by immunofluorescence. Protein expressions of nuclear factor E2 related factor 2 (Nrf2) and transforming growth factor-beta (TGF-β)/SMAD pathway-related genes were detected by Western blot. RESULTS: Serum levels of Cr and BUN in ω-3 PUFAs group were remarkably decreased compared with those of adenine group. Higher contents of SOD, GSH, CAT and T-AOC were observed in ω-3 PUFAs group compared with those of adenine group. Besides, MAD content and ROS production were lower in ω-3 PUFAs group than those of adenine group. Pathological changes of kidneys were alleviated after ω-3 PUFAs treatment. Western blot results demonstrated that ω-3 PUFAs treatment remarkably upregulates Nrf2, HO-1, NQO1, but downregulates relative genes in TGF-β/SMAD pathway. CONCLUSIONS: ω-3 PUFAs alleviated adenine-induced chronic renal failure through enhancing antioxidant stress and inhibiting inflammatory response via regulating Nrf2 and TGF-β/SMAD pathway.
机译:目的:探讨ω-3多不饱和脂肪酸(ω-3PUFAs)在腺嘌呤诱发的大鼠慢性肾功能衰竭中的作用及其潜在机制。材料与方法:30只SD大鼠随机分为三组,即假手术组,腺嘌呤诱导组(腺嘌呤组)和腺嘌呤诱导+ω-3PUFAs治疗组(ω-3PUFAs组),每组10只在每个组中。处死大鼠后收集血清和肾脏样品。使用商业试剂盒检测血清中的Cr(肌酐)和BUN(尿素氮)水平。进行HE(苏木精和曙红)染色以评估肾脏的病理变化。用相对商业的试剂盒检测了大鼠肾脏匀浆中氧化应激指标的水平,包括SOD(超氧化物歧化酶),GSH(还原型谷胱甘肽),CAT(过氧化氢酶)和T-AOC(总抗氧化能力)。还通过免疫荧光检测了活性氧(ROS)的产生。 Western blot检测核因子E2相关因子2(Nrf2)和转化生长因子-β(TGF-β)/ SMAD途径相关基因的蛋白表达。结果:与腺嘌呤组相比,ω-3PUFAs组血清Cr和BUN水平明显降低。与腺嘌呤组相比,ω-3PUFAs组的SOD,GSH,CAT和T-AOC含量更高。此外,ω-3PUFAs组的MAD含量和ROS的产生均低于腺嘌呤组。 ω-3PUFAs治疗后肾脏的病理改变得到缓解。蛋白质印迹结果表明,ω-3PUFAs处理显着上调Nrf2,HO-1,NQO1,但下调TGF-β/ SMAD途径中的相关基因。结论:ω-3PUFA通过增强抗氧化应激和通过调节Nrf2和TGF-β/ SMAD途径抑制炎症反应,减轻了腺嘌呤诱发的慢性肾功能衰竭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号